Dr Kwang Chin
Clinical (Senior Lecturer)
The Sir Peter MacCallum Department of Oncology
14 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Defining an Unresectable Primary Retroperitoneal Sarcoma
DOI: 10.1111/ans.702492025
Journal article
Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial
DOI: 10.1016/S1470-2045(25)00559-52025
Journal article
2386P A phase I/II trial of combined Radium-223 and Lutetium-177 PSMA-I&T in patients with metastatic castration-resistant prostate cancer (mCRPC): First analysis of the AlphaBet trial
DOI: 10.1016/j.annonc.2025.08.30022025
Journal article
Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial
DOI: 10.3390/cancers171017272025
Journal article
Comparing Outcomes of Per-Oral Image-Guided Gastrostomy With Radiologically Inserted Gastrostomy at a Quaternary Australian Hospital
DOI: 10.1111/1754-9485.138352023
Conference Proceedings
AlphaBet: A Phase I/II trial evaluating the combination of Radium-223 and [177Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer
2023
Conference Proceedings
AlphaBet: A phase I/II trial evaluating the combination of radium-223 and [177Lu]Lu-PSMAI&T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
DOI: 10.1200/jco.2023.41.6_suppl.tps280
RECENT SCHOLARLY WORKS
2022
Journal article
AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)
DOI: 10.3389/fmed.2022.10591222021
Journal article
Do antispasmodics or rectal enemas improve image quality on multiparametric prostate MRI? An ‘Evidence-Based Practice’ review of the literature
DOI: 10.1007/s00261-020-02916-62017
Journal article
Multiparametric magnetic resonance imaging for prostate cancer—a comparative study including radical prostatectomy specimens
DOI: 10.1007/s00345-016-1960-x